Standigm's SPICA is a state-of-the-art predictive tool designed to assess the patentability of drug candidates swiftly and accurately. It utilizes a machine learning model trained on an extensive dataset of patent information, allowing it to provide insights into the likelihood of patent conflicts and the novelty of the compound.